1. Home
  2. NBH vs STIM Comparison

NBH vs STIM Comparison

Compare NBH & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBH
  • STIM
  • Stock Information
  • Founded
  • NBH 2002
  • STIM 2003
  • Country
  • NBH United States
  • STIM United States
  • Employees
  • NBH N/A
  • STIM N/A
  • Industry
  • NBH Finance/Investors Services
  • STIM Medical/Dental Instruments
  • Sector
  • NBH Finance
  • STIM Health Care
  • Exchange
  • NBH Nasdaq
  • STIM Nasdaq
  • Market Cap
  • NBH 288.5M
  • STIM 232.3M
  • IPO Year
  • NBH N/A
  • STIM 2018
  • Fundamental
  • Price
  • NBH $9.87
  • STIM $3.91
  • Analyst Decision
  • NBH
  • STIM Buy
  • Analyst Count
  • NBH 0
  • STIM 4
  • Target Price
  • NBH N/A
  • STIM $6.00
  • AVG Volume (30 Days)
  • NBH 85.9K
  • STIM 885.6K
  • Earning Date
  • NBH 01-01-0001
  • STIM 05-06-2025
  • Dividend Yield
  • NBH 4.34%
  • STIM N/A
  • EPS Growth
  • NBH N/A
  • STIM N/A
  • EPS
  • NBH 0.12
  • STIM N/A
  • Revenue
  • NBH N/A
  • STIM $89,448,000.00
  • Revenue This Year
  • NBH N/A
  • STIM $104.65
  • Revenue Next Year
  • NBH N/A
  • STIM $10.69
  • P/E Ratio
  • NBH $87.04
  • STIM N/A
  • Revenue Growth
  • NBH N/A
  • STIM 22.16
  • 52 Week Low
  • NBH $8.75
  • STIM $0.52
  • 52 Week High
  • NBH $11.01
  • STIM $5.92
  • Technical
  • Relative Strength Index (RSI)
  • NBH 39.25
  • STIM 41.16
  • Support Level
  • NBH $9.86
  • STIM $3.78
  • Resistance Level
  • NBH $9.99
  • STIM $4.00
  • Average True Range (ATR)
  • NBH 0.11
  • STIM 0.26
  • MACD
  • NBH -0.01
  • STIM -0.05
  • Stochastic Oscillator
  • NBH 17.39
  • STIM 15.12

About NBH Neuberger Berman Municipal Fund Inc.

Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: